Intrapulmonary versus nasal transduction of murine airways with GP64-pseudotyped viral vectors

Molecular Therapy Nucleic Acids

Volumn 2, Issue , 2013, Pages

  Oakland, Mayumi ^a   Maury, Wendy ^a   McCray, Paul B ^a   Sinn, Patrick L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

FIV; gene therapy; lentiviral vector

Indexed keywords

ADENOVIRUS VECTOR; GLYCOPROTEIN 64; INTERFERON; LENTIVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

AIRWAY; AIRWAY CONDUCTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; FELINE IMMUNODEFICIENCY VIRUS; GENE THERAPY; GENE TRANSFER; MOUSE; NEUTROPHIL; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; T LYMPHOCYTE; TRACHEA MUCOSA; VESICULAR STOMATITIS VIRUS;

EID: 84878886484     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2012.60     Document Type: Article

References (51)

1. Driskell, RA and Engelhardt, JF (2003). Current status of gene therapy for inherited lung diseases. Annu Rev Physiol 65: 585-612. (Pubitemid 38249169)
2. O'Dea, S and Harrison, DJ (2002). CFTR gene transfer to lung epithelium-on the trail of a target cell. Curr Gene Ther 2: 173-181.
3. McCormack, JE, Martineau, D, DePolo, N, Maifert, S, Akbarian, L, Townsend, K et al. (1997). Anti-vector immunoglobulin induced by retroviral vectors. Hum Gene Ther 8: 1263-1273. (Pubitemid 27394134)
4. Sinn, PL, Sauter, SL and McCray, PB Jr (2005). Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors-design, biosafety, and production. Gene Ther 12: 1089-1098. (Pubitemid 41030614)
5. Stocker, AG, Kremer, KL, Koldej, R, Miller, DS, Anson, DS and Parsons, DW (2009). Singledose lentiviral gene transfer for lifetime airway gene expression. J Gene Med 11: 861-867.
6. Sinn, PL, Goreham-Voss, JD, Arias, AC, Hickey, MA, Maury, W, Chikkanna-Gowda, CP et al. (2007). Enhanced gene expression conferred by stepwise modification of a nonprimate lentiviral vector. Hum Gene Ther 18: 1244-1252. (Pubitemid 350261962)
7. Johnston, JC, Gasmi, M, Lim, LE, Elder, JH, Yee, JK, Jolly, DJ et al. (1999). Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol 73: 4991-5000. (Pubitemid 29246760)
8. Roche, WR, Montefort, S, Baker, J and Holgate, ST (1993). Cell adhesion molecules and the bronchial epithelium. Am Rev Respir Dis 148(6 Pt 2): S79-S82. (Pubitemid 24002525)
9. Knowles, MR and Boucher, RC (2002). Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109: 571-577. (Pubitemid 34204834)
10. Kang, Y, Stein, CS, Heth, JA, Sinn, PL, Penisten, AK, Staber, PD et al. (2002). In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins. J Virol 76: 9378-9388. (Pubitemid 34919895)
11. Sinn, PL, Burnight, ER, Hickey, MA, Blissard, GW and McCray, PB Jr (2005). Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J Virol 79: 12818-12827. (Pubitemid 41433201)
12. Sinn, PL, Hickey, MA, Staber, PD, Dylla, DE, Jeffers, SA, Davidson, BL et al. (2003). Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol 77: 5902-5910. (Pubitemid 36538982)
13. Sinn, PL, Penisten, AK, Burnight, ER, Hickey, MA, Williams, G, McCoy, DM et al. (2005). Gene transfer to respiratory epithelia with lentivirus pseudotyped with Jaagsiekte sheep retrovirus envelope glycoprotein. Hum Gene Ther 16: 479-488. (Pubitemid 40647145)
14. Sinn, PL, Arias, AC, Brogden, KA and McCray, PB Jr (2008). Lentivirus vector can be readministered to nasal epithelia without blocking immune responses. J Virol 82: 10684-10692. (Pubitemid 352691165)
15. Sinn, PL, Anthony, RM and McCray, PB Jr (2011). Genetic therapies for cystic fibrosis lung disease. Hum Mol Genet 20(R1): R79-R86.
16. Sinn, PL, Burnight, ER and McCray, PB Jr (2009). Progress and prospects: prospects of repeated pulmonary administration of viral vectors. Gene Ther 16: 1059-1065.
17. Sinn, PL, Shah, AJ, Donovan, MD and McCray, PB Jr (2005). Viscoelastic gel formulations enhance airway epithelial gene transfer with viral vectors. Am J Respir Cell Mol Biol 32: 404-410. (Pubitemid 40629325)
18. Otake, K, Ennist, DL, Harrod, K and Trapnell, BC (1998). Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses. Hum Gene Ther 9: 2207-2222. (Pubitemid 28498007)
19. Nathan, C (2006). Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6: 173-182. (Pubitemid 43290987)
20. Daley, JM, Thomay, AA, Connolly, MD, Reichner, JS and Albina, JE (2008). Use of Ly6Gspecific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 83: 64-70.
21. Worgall, S, Leopold, PL, Wolff, G, Ferris, B, Van Roijen, N and Crystal, RG (1997). Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Hum Gene Ther 8: 1675-1684. (Pubitemid 28031586)
22. McCray, PB Jr, Wang, G, Kline, JN, Zabner, J, Chada, S, Jolly, DJ et al. (1997). Alveolar macrophages inhibit retrovirus-mediated gene transfer to airway epithelia. Hum Gene Ther 8: 1087-1093. (Pubitemid 27308206)
23. Muller, U, Steinhoff, U, Reis, LF, Hemmi, S, Pavlovic, J, Zinkernagel, RM et al. (1994). Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921. (Pubitemid 24245635)
24. Mombaerts, P, Iacomini, J, Johnson, RS, Herrup, K, Tonegawa, S and Papaioannou, VE (1992). RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
25. Oakland, M, Sinn, PL and McCray, PB Jr (2012). Advances in cell and gene-based therapies for cystic fibrosis lung disease. Mol Ther 20: 1108-1115.
26. Antunes, MB, Woodworth, BA, Bhargave, G, Xiong, G, Aguilar, JL, Ratner, AJ et al. (2007). Murine nasal septa for respiratory epithelial air-liquid interface cultures. BioTechniques 43: 195-6, 198, 200 passim.
27. Woodworth, BA, Antunes, MB, Bhargave, G, Palmer, JN and Cohen, NA (2007). Murine tracheal and nasal septal epithelium for air-liquid interface cultures: a comparative study. Am J Rhinol 21: 533-537. (Pubitemid 350099760)
28. Hefferon, KL, Oomens, AG, Monsma, SA, Finnerty, CM and Blissard, GW (1999). Host cell receptor binding by baculovirus GP64 and kinetics of virion entry. Virology 258: 455-468. (Pubitemid 29390256)
29. Zhou, J and Blissard, GW (2008). Identification of a GP64 subdomain involved in receptor binding by budded virions of the baculovirus Autographica californica multicapsid nucleopolyhedrovirus. J Virol 82: 4449-4460. (Pubitemid 351563681)
30. Brierley, MM and Fish, EN (2002). Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry. J Interferon Cytokine Res 22: 835-845. (Pubitemid 35217514)
31. Brown, BD, Sitia, G, Annoni, A, Hauben, E, Sergi, LS, Zingale, A et al. (2007). In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 109: 2797-2805. (Pubitemid 46482074)
32. Limberis, MP, Bell, CL, Heath, J and Wilson, JM (2010). Activation of transgene-specific T cells following lentivirus-mediated gene delivery to mouse lung. Mol Ther 18: 143-150.
33. Buckley, SM, Howe, SJ, Sheard, V, Ward, NJ, Coutelle, C, Thrasher, AJ et al. (2008). Lentiviral transduction of the murine lung provides efficient pseudotype and developmental stage-dependent cell-specific transgene expression. Gene Ther 15: 1167-1175.
34. Sinn, PL, Burnight, ER, Hickey, MA, Blissard, GW and McCray, PB Jr (2005). Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J Virol 79: 12818-12827. (Pubitemid 41433201)
35. Bieniasz, PD and Cullen, BR (2000). Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J Virol 74: 9868-9877.
36. Keppler, OT, Yonemoto, W, Welte, FJ, Patton, KS, Iacovides, D, Atchison, RE et al. (2001). Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J Virol 75: 8063-8073. (Pubitemid 32743678)
37. Koito, A, Shigekane, H and Matsushita, S (2003). Ability of small animal cells to support the postintegration phase of human immunodeficiency virus type-1 replication. Virology 305: 181-191. (Pubitemid 36062822)
38. Mariani, R, Rutter, G, Harris, ME, Hope, TJ, Krausslich, HG and Landau, NR (2000). A block to human immunodeficiency virus type 1 assembly in murine cells. J Virol 74: 3859-3870. (Pubitemid 30180328)
39. Tsurutani, N, Yasuda, J, Yamamoto, N, Choi, BI, Kadoki, M and Iwakura, Y (2007). Nuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells. J Virol 81: 677-688. (Pubitemid 46067894)
40. Kirchhoff, F (2010). Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8: 55-67.
41. Kondratowicz, AS, Lennemann, NJ, Sinn, PL, Davey, RA, Hunt, CL, Moller-Tank, S et al. (2011). T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc Natl Acad Sci USA 108: 8426-8431.
42. Rogers, CS, Abraham, WM, Brogden, KA, Engelhardt, JF, Fisher, JT, McCray, PB Jr et al. (2008). The porcine lung as a potential model for cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 295: L240-L263.
43. Rogers, CS, Hao, Y, Rokhlina, T, Samuel, M, Stoltz, DA, Li, Y et al. (2008). Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. J Clin Invest 118: 1571-1577. (Pubitemid 351500450)
44. Rogers, CS, Stoltz, DA, Meyerholz, DK, Ostedgaard, LS, Rokhlina, T, Taft, PJ et al. (2008). Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321: 1837-1841.
45. Ostedgaard, LS, Meyerholz, DK, Chen, JH, Pezzulo, AA, Karp, PH, Rokhlina, T et al. (2011). The F508 mutation causes CFTR misprocessing and cystic fibrosis-like disease in pigs. Sci Transl Med 3: 74ra24.
46. Sun, X, Sui, H, Fisher, JT, Yan, Z, Liu, X, Cho, HJ et al. (2010). Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest 120: 3149-3160.
47. McLachlan, G, Davidson, H, Holder, E, Davies, LA, Pringle, IA, Sumner-Jones, SG et al. (2011). Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung. Gene Ther 18: 996-1005.
48. McLachlan, G, Baker, A, Tennant, P, Gordon, C, Vrettou, C, Renwick, L et al. (2007). Optimizing aerosol gene delivery and expression in the ovine lung. Mol Ther 15: 348-354. (Pubitemid 46111885)
49. Wang, G, Slepushkin, V, Zabner, J, Keshavjee, S, Johnston, JC, Sauter, SL et al. (1999). Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J Clin Invest 104: R55-R62. (Pubitemid 30002376)
50. Whelan, SP, Ball, LA, Barr, JN and Wertz, GT (1995). Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc Natl Acad Sci USA 92: 8388-8392.
51. Karp, PH, Moninger, TO, Weber, SP, Nesselhauf, TS, Launspach, JL, Zabner, J et al. (2002). An in vitro model of differentiated human airway epithelia. Methods for establishing primary cultures. Methods Mol Biol 188: 115-137.